ABSTRACf. We investigated the influence of exogenously administered acetylcholine, nitric oxide, ADP, ATP , bradykinin, and substance P on coronary vascular tone in isolated , neonatal pig hearts (s4 d). Paced (180 bpm), isovolumically beating hearts underwent retrograde aortic perfusion , with an erythrocyte-enriched solution (hematocrit 0.15-0.20) at constant coronary flow (~2.5 mL/min/g) corresponding to a perfusion pressure of~60 mm Hg. Agonists were injected into the aortic root, and the peak change in coronary perfusion pressure from baseline and left ventricular pressure development were assessed. Nitric oxide (3 JLL), ADP (30 nmol), ATP (30 nmol), bradykinin (125 ng), and substance P (50 ng) decreased the perfusion pressure (vasodilatation) by 16.9 ± 1.2, 25.3 ± 4.4, 18.3 ± 1.2, 18.9 ± 1.4, and 7.1 ± 1.6 mm Hg, respectively. Acetylcholine (0.5 and 1.0 nmol) produced a modest decrease in perfusion pressure (vasodilatation) of 4.2 ± 0.8 and 3.8 ± 0.5 mm Hg, respectivel y, whereas acetylcholine (5, 20, and 100 nmol) increased the perfusion pre ssure (vasoconstriction) by 16.7 ± 2.7, 48.2 ± 8.2, and 85.3 ± 15.1 mm Hg, respectively. Acetylcholine also decreased left ventricular peak systolic pres sure from 108.7 ± 5.0 to 69.2 ± 4.6, 56.3 ± 6.1, and 48.2 ± 6.4 mm Hg, for the 5, 20, and 100 nmol doses, respectively. Responses to acetylcholine were abolished by atropine (50 nmol). In a separate group of hearts, indomethacin (10-6 M) reduced the peak change in perfusion pressure for the 5, 20, and 100 nmol doses of acetylcholine by 87% ,66%, and 48%, respectively. In other hearts, the calcium channel antagonist, nisoldipine (10-7 M), reduced the peak change in perfusion pre ssure for the 5,20, and 100 nmol doses of acetylcholine by 87 %, 77%, and 56%, respectivel y. In summary, acetylcholine causes predominantly coronary vasoconstrictive and negative inotropic effects in neonatal pig hearts; both actions are muscarinic receptor mediated. Our data also indicate that a cyclooxygenase product may, in part, be involved in this vasoconstriction, and that an extracellular source of calcium contributes to the vasoconstrictive process. (Pediatr Res 32: 236-242, 1992) Abbreviations ACh, acet ylcholine EDRF, endothelium-derived relaxing factor BK, brad ykinin sub P, substance P NO , nitric oxide PSP, peak systolic pressure dP/dt, change in pressure per unit time Some 30 years ago, Cassin et al. (I) showed that ACh dilates the normally high tone pulmonary vasculature of the fetus. More recently, ACh has been shown to be a potent dilator of precontra cted, isolated systemic and pulmon ary arteries from neonates of several species (2). As originally demonstrated by Furchgott and Zawadzki (3), the vasorelaxation produced by ACh requires the presence of a functionally intact end othel ium and involves the produ ction of an EDRF. ACh has also been shown to relax precontracted, epicardial coro nary arteries isolated from several species, mo st notably the dog (4). It has becom e apparent, however, that the se results cannot b...